Tamiflu (oseltamivir phosphate) Information
Tamiflu (oseltamivir phosphate) is an oral anti-viral drug approved for the treatment of acute, uncomplicated influenza in patients 2 weeks of age and older whose flu symptoms have not lasted more than two days. This product is approved to treat Type A and B influenza; however, the majority of patients included in the studies were infected with type A, the most common in the U.S. Efficacy of Tamiflu in the treatment of influenza in subjects with chronic cardiac disease and/or respiratory disease has not been established.
Tamiflu is also approved for the prevention of influenza in adults and children aged one year and older. Efficacy of Tamiflu for the prevention of influenza has not been established in immunocompromised patients.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
Brief Shortage of Tamiflu Oral Suspension
FDA expands Tamiflu’s use to treat children younger than 1 year[ARCHIVED]
FDA Drug Safety Communication: Important safety changes to the influenza drug Tamiflu (oseltamivir phosphate) for oral suspension
Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes sobre la seguridad del medicamento para la influenza Tamiflu (fosfato de oseltamivir) para suspensión oral
7/11/2011 FDA Drug Safety Communication in Spanish
FDA Drug Safety Podcast for Healthcare Professionals: Important safety changes to the influenza drug Tamiflu (oseltamivir phosphate) for oral suspension[ARCHIVED]
Concentration Lowered in Tamiflu Medication
FDA Consumer Update
FDA Sounds Alarm on Phony Tamiflu[ARCHIVED]
Tamiflu: Consumer Questions and Answers
- FDA Public Health Alert: Potential Medication Errors with Tamiflu for Oral Suspension (9/25/2009) [ARCHIVED]
Note: Tamiflu Oral Suspension formulation was changed after report of these medication errors. Refer to the 'Prescribing Information' link below for up-to-date product information.
Tamiflu (oseltamivir phosphate)[ARCHIVED]
MedWatch Safety Alert (Posted 3/4/2008)
Historical Information on Tamiflu (oseltamivir phosphate)[ARCHIVED]